Trials / Completed
CompletedNCT01987752
Safety and Efficacy of Combigan® Ophthalmic Solution in Korea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 732 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and efficacy of Combigan® (brimonidine tartrate/timolol maleate) Ophthalmic Solution in patients with Open Angle Glaucoma or Ocular hypertension with insufficient response to local beta blockers treated as per standard of care in clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | brimonidine tartrate/timolol maleate Ophthalmic Solution | brimonidine tartrate/timolol maleate (Combigan®) Ophthalmic Solution as per local standard of care in clinical practice. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2013-11-19
- Last updated
- 2014-04-04
- Results posted
- 2014-04-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01987752. Inclusion in this directory is not an endorsement.